Case series reveals effective treatment of moderate-to-severe atopic dermatitis in children, suggesting potential in management.
Atopic dermatitis (AD) is a chronic skin disease most commonly affecting children. The pathophysiology is thought to be influenced by the JAK-STAT signalling system. There are very few studies showing the efficacy of JAK-STAT inhibitors in AD. Here, we present the case series of seven pediatric patients treated successfully with oral tofacitinib.
No takes yet. Share an insight, caveat, or question.
Bhattacharya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: